Trials / Completed
CompletedNCT00850733
516-BOTOX Urinary Incontinence Detrusor
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of Safety and Efficacy of a Single Treatment With 2 Dose Levels of BOTOX Purified Neurotoxin Complex Followed by a Treatment With BOTOX in Patients With…
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Veterans Medical Research Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The specific aim of this study is to evaluate the safety and efficacy of each of 2 dosages of BOTOX® (200 U or 300 U) compared to placebo injected into the detrusor for the treatment of urinary incontinence caused by neurogenic detrusor overactivity in patients who have not been adequately managed with anticholinergic therapy.
Conditions
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2009-02-25
- Last updated
- 2009-09-17
Source: ClinicalTrials.gov record NCT00850733. Inclusion in this directory is not an endorsement.